Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Chemically Synthesized Medicines
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +86.52% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +86.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Lee
CEO | Chief Executive Officer | 56 | 15-08-31 |
Alethia Young
DFI | Director of Finance/CFO | 45 | 23-07-16 |
Alistair Milnes
COO | Chief Operating Officer | 50 | 20-12-31 |
Michael Skynner
CTO | Chief Tech/Sci/R&D Officer | 55 | 15-12-31 |
Nicholas Keen
CTO | Chief Tech/Sci/R&D Officer | 56 | 16-12-31 |
David Borah
IRC | Investor Relations Contact | - | 21-03-31 |
Jennifer Perry
PRN | Corporate Officer/Principal | - | - |
Travis Thompson
AUD | Comptroller/Controller/Auditor | - | 18-03-31 |
Zafar Qadir
LAW | General Counsel | - | 20-04-22 |
Santiago Arroyo
PRN | Corporate Officer/Principal | 64 | 23-03-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pierre Legault
CHM | Chairman | 63 | 19-03-17 |
Director/Board Member | 61 | 21-03-16 | |
Veronica Jordan
BRD | Director/Board Member | 73 | 19-10-30 |
Richard Kender
BRD | Director/Board Member | 68 | 19-07-23 |
Janice Bourque
BRD | Director/Board Member | 67 | 19-07-17 |
Gregory Winter
FOU | Founder | 73 | 08-12-31 |
Kevin Lee
CEO | Chief Executive Officer | 56 | 15-08-31 |
Stephen Sands
BRD | Director/Board Member | - | Feb. 19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,880,303 | 4,333,333 ( 11.44 %) | 0 | 11.44 % |
Company contact information
Bicycle Therapeutics Plc
Granta Park Great Abington Portway Building
CB21 6GS, Cambridge
+44 1223 261 503
http://bicycletherapeutics.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+8.24% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |